Preeclampsia as a life-threatening condition


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. To investigate clinical and laboratory criteria for the “reference point” of the progression of severe preeclampsia (PE) into a life-threatening condition with a different outcome (near miss or maternal death). Subjects and methods. The investigators conducted a multicenter study conducted through an examination of 18,130 records of severe PE-complicated labors and deliveries. The study period was January 1, 2013 to December 31, 2018. There were 27 Moscow participating centers. A total of 122 delivery records were selected from women with PE and life-threatening conditions that led to near misses in 100 patients (a near miss group) and to maternal deaths in 22 women (a MD group). Results. Within less than 24 hours, severe PE can develop into a life-threatening condition and result in MD in women aged 18-45 years after natural conception at 24 weeks’ gestation (up to 34 weeks in 50%), with a blood pressure of less than 160/100 mm Hg, the baseline level of creatinine from 33.0 to 349.5pmol/E and its increase by 9.47 times, that of platelets from 10.0 to 362.0109/E and their increase by 0.04-1.0 time, that of bilirubin from 5.0 to 104.0 pmol/E and its increase by 1.56-24.63 times, that of AET from 8.7 to 807.0 U/E and its increase by 1.0-318.8 times, that of AST from 15.0 to 1238.0 U/E and its increase by 1.68-429.53 times, that of EDH from 568,4 to 2315,0 U/E and its increase by 2.79-9.89 times; moreover, 22.73% of cases can have no pathognomonic complaints and have a satisfactory general condition. Conclusion. PE should be considered as a condition with much more variability in outcomes, such as pre-stroke, pre-HEEEP syndrome, pre-hepatic, prerenal, or multiple organ dysfunctions, etc. It is extremely difficult to predict MD. PE can manifest as a life-threatening condition within a few hours, possibly in the absence of elevated blood pressure. Critical liver fa ilure competes by signif icance in the risks of MD with high blood pressure. The reference point from the diagnosis of PE to a life-threatening condition may be accompanied by the values of clinical and laboratory markers, which do not meet not only the criteria for near miss, but also severe PE. Timely delivery tactics is a fundamental measure for the prevention of life-threatening complications and MD.

Full Text

Restricted Access

About the authors

Anton S. Olenev

Peoples' Friendship University of Russia

Email: olenevAS@zdrav.mos.ru

Vladislava A. Novikova

Peoples' Friendship University of Russia

Email: vladislavan@mail.ru

Victor E. Radzinsky

Peoples' Friendship University of Russia

Email: kafedra-aig@mail.ru

References

  1. Радзинский В.Е., Фукс А.М. Акушерство. Учебник. М.: ГЭОТАР-Медиа; 2016. 1040 с.
  2. Evaluating the quality of care for severe pregnancy complications. The WHO near-miss approach for maternal health. World Health Organization; 2011. Available at: http://whqlibdoc.who.int/./2011/9789241502221
  3. Федеральная служба государственной статистики. 2017. Доступно по: http://www.gks.ru/free_doc/doc_2017/bul_dr/edn/edn17-g.xlsx
  4. Гипертензивные расстройства во время беременности, в родах и послеродовом периоде. Преэклампсия. Эклампсия. Клинические рекомендации (протокол лечения). М.; 2016. 72 с.
  5. Организация медицинской эвакуации беременных женщин, рожениц и родильниц при неотложных состояниях. Клинические рекомендации (протокол лечения). Медицинский алфавит. 2016; 2[15(278)]: 50-3.
  6. Poon L.C., Shennan A., Hyett J.A., Kapur A., Hadar E., Divakar H. et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention. Int. J. Gynaecol. Obstet. 2019; 145(Suppl. 1): 1-33. https://doi.org/10.1002/ ijgo.12802.
  7. ACOG Practice Bulletin No. 202: Gestational hypertension and preeclampsia. Obstet. Gynecol. 2019; 133(1): e1-25. https://doi.org/10.1097/ AOG.0000000000003018.
  8. th Revision of the International Classification of Diseases (ICD- 11). Geneva: World Health Organization; 2018
  9. Сидорова И.С., Никитина Н.А., Унанян А.Л. Преэклампсия и снижение материнской смертности в России. Акушерство и гинекология. 2018; 1: 107-12. https://dx.doi.org/10.18565/aig.2018.1.107-112.
  10. Сидорова И.С., Никитина Н.А. Преэклампсия как гестационный иммунокомплексный комплементоопосредованный эндотелиоз. Российский вестник акушера-гинеколога. 2019; 19(1): 5-11. https://doi.org/10.17116/ rosakush2019190115.
  11. Sibai B.M., Stella C.L. Diagnosis and management of atypical preeclampsia-eclampsia. Am. J. Obstet. Gynecol. 2009; 200(5): 481. e1-7. https://doi. org/10.1016/j.ajog.2008.07.048.
  12. Савельева Г.М., Шалина Р.И., Коноплянников А.Г., Симухина М.А. Преэклампсия и эклампсия: новые подходы к диагностике и оценке степени тяжести. Акушерство и гинекология: новости, мнения, обучение. 2018; 6(4): 25-30. https://doi.org/10.24411/2303-9698-2018-14002.
  13. Berhan Y. No hypertensive disorder of pregnancy; No preeclampsia-eclampsia; No gestational hypertension; No hellp syndrome. Vascular disorder of pregnancy speaks for all. Ethiop. J. Health Sci. 2016; 26(2): 177-86.
  14. Михалёва Л.М., Грачева Н.А., Бирюков А.Е. Клинико-анатомические аспекты преэклампсии: современные особенности течения. Архив патологии. 2018; 80(2): 11-7. https://doi.org/10.17116/patol201880211-17.
  15. Rana S., Lemoine E., Granger J., Karumanchi S. Preeclampsia: pathophysiology, challenges, and perspectives. Circ. Res. 2019; 124(7): 1094-112. https://doi. org/10.1161/CIRCRESAHA.118.313276.
  16. Мамонтова И.К., Шевлякова Т.В., Петрова Е.И. «Near miss» в акушерстве: место в оценке технологий здравоохранения, подходы к классифика ции и оценке. Фармакоэкономика. Современная фармакоэкономика и фармакоэпидемиология. 2018; 12(4): 92-6. https://doi.org/10.17749/2313-7347.2018.11.4.092-096.
  17. Samyel-Agwany A., Abdelsadek A. Abdelhadi. A rare case of normotensive HELLP syndrome complicated with massive ascites: Spontaneous resolution. Egypt. J. Anaesth. 2016; 32(1): 155-8. https://doi.org/10.1016/j.egja.2015.09.003
  18. Leeman L., Dresang L.T., Fontaine P. Hypertensive disorders of pregnancy. Am. Fam. Physician. 2016; 93(2): 121-7. PMID: 26926408
  19. Basit S., Wohlfahrt J., Boyd H.A. Pre-eclampsia and risk of dementia later in life: nationwide cohort study. BMJ. 2018; 363: k4109. https://doi.org/10.1136/ bmj.k4109.
  20. Brown M.C., Best K.E., Pearce M.S., Waugh J., Robson S.C., Bell R. Cardiovascular disease risk in women with pre-eclampsia: systematic review and meta-analysis. Eur. J. Epidemiol. 2013; 28(1): 1-19. https://doi.org/10.1007/ s10654-013-9762-6.
  21. Новикова В.А., Юсупова З.С., Шаповалова О.А., Хорольский В.А. Обоснование контроля реконвалесценции и индивидуальной реабилитации у женщин, перенесших тяжелую преэклампсию. Кубанский научный медицинский вестник. 2018; 25(3): 73-81.
  22. Кирсанова Т.В., Виноградова М.А., Колыванова А.И., Шмаков Р.Г. HELLP-синдром: клинико-лабораторные особенности и дисбаланс плацентарных факторов ангиогенеза. Акушерство и гинекология. 2018; 7: 46-55. https://dx.doi.org/10.18565/aig.2018.7.46-55

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2020 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies